Skip to main content

Animations

MJFF Publications

8311 - 8320 of 9039 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2020
  • 2024
  • 2020
  • 2020
  • 2019
  • 2024
  • 2020
  • Summary Details
    OPEN
    Title: Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2318943121
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Role of GBA variants in Lewy body disease neuropathology
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-024-02699-w
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Development and Implementation of an Innovative Framework for Automated Radiomics Analysis in Neuroimaging
    Journal Name: Journal of Imaging
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/jimaging10040096
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Association of specific biotypes in patients with Parkinson disease and disease progression
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000010498
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Lysosomal genes contribute to Parkinson’s disease near agriculture with high intensity pesticide use
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00703-4
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Distribution of Parkinson’s disease associated RAB39B in mouse brain tissue
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-020-00584-7
    Citation Count: 12
  • Summary Details
    OPEN
    Title: A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-020-00370-y
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Participation and consultation engagement strategies have complementary roles: A case study of patient and public involvement in clinical practice guideline development
    Journal Name: Health Expectations
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/hex.13018
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1002/dad2.12589
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2019.11.013
    Citation Count: 224
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.